Arif O. Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arif O. Khan has a total of 290 co-authors. Here are the top co-authors by number of shared publications:
- Mohammed A. Aldahmesh
Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
31 shared publications Fowzan S. Alkuraya
C Department of Genetics , King Faisal Specialist Hospital and Research Center , Riyadh , Saudi Arabia
22 shared publications- Brian Francis Meyer
Genetics Department, King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, Riyadh 11211, Saudi Arabia
8 shared publications - Nada Al-Tassan
Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
8 shared publications Jawahir Y. Mohamed
7 shared publicationsDarren T. Oystreck
Department of OphthalmologyCollege of MedicineKing Saud UniversityRiyadh,Saudi Arabia
6 shared publications
Latest Publications
- Open Access
- 9 October 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (23)
Biallelic variants in ARHGAP19 cause a progressive inherited motor-predominant neuropathy
Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of hereditary neuropathies. Despite progress in genetic sequencing, for around a quarter of patients the disease has lacked a genetic explanation. Here, we identified 16 recessive variants in the RhoGTPase activating protein 19 gene ( ARHGAP19 ) causing motor-predominant neuropathy in 25 individuals from 20 unrelated families. The ARHGAP19 protein acts as a negative regulator of the RhoA GTPase. In vitro biochemical and cellular assays revealed that patient variants impair the GTPase-activating protein (GAP) activity of ARHGAP19 and reduce ARHGAP19 protein levels. Through the use of patient lines, in vitro GAP assays and in silico molecular modeling, we provided evidence that CMT-associated ARHGAP19 variants act through a loss-of-function (LOF) mechanism. LOF in ARHGAP19 orthologues in Drosophila melanogaster and Danio rerio induced motor defects in axonal and synaptic morphology. Similar cellular phenotypes were observed in ARHGAP19 patient-derived motoneurons. Transcriptomic studies further demonstrated that ARHGAP19 regulates cellular pathways associated with motor proteins and the cell cycle. Taken together, our findings establish ARHGAP19 variants as a cause of inherited neuropathy acting through a LOF mechanism.
- 9 October 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (23)
Open AccessBiallelic variants in ARHGAP19 cause a progressive inherited motor-predominant neuropathy
Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of hereditary neuropathies. Despite progress in genetic sequencing, for around a quarter of patients the disease has lacked a genetic explanation. Here, we identified 16 recessive variants in the RhoGTPase activating protein 19 gene ( ARHGAP19 ) causing motor-predominant neuropathy in 25 individuals from 20 unrelated families. The ARHGAP19 protein acts as a negative regulator of the RhoA GTPase. In vitro biochemical and cellular assays revealed that patient variants impair the GTPase-activating protein (GAP) activity of ARHGAP19 and reduce ARHGAP19 protein levels. Through the use of patient lines, in vitro GAP assays and in silico molecular modeling, we provided evidence that CMT-associated ARHGAP19 variants act through a loss-of-function (LOF) mechanism. LOF in ARHGAP19 orthologues in Drosophila melanogaster and Danio rerio induced motor defects in axonal and synaptic morphology. Similar cellular phenotypes were observed in ARHGAP19 patient-derived motoneurons. Transcriptomic studies further demonstrated that ARHGAP19 regulates cellular pathways associated with motor proteins and the cell cycle. Taken together, our findings establish ARHGAP19 variants as a cause of inherited neuropathy acting through a LOF mechanism.
- Open Access
Ocular-Induced Abnormal Head Posture: Diagnosis and Missing Data Imputation
Ocular-induced abnormal head posture (AHP) is a compensatory mechanism that arises from ocular misalignment conditions, such as strabismus, enabling patients to reduce diplopia and preserve binocular vision. Early diagnosis minimizes morbidity and secondary complications such as facial asymmetry; however, current clinical assessments remain largely subjective and are further complicated by incomplete medical records. This study addresses both challenges through two complementary deep learning frameworks. First, AHP-CADNet is a multi-level attention fusion framework for automated diagnosis that integrates ocular landmarks, head pose features, and structured clinical attributes to generate interpretable predictions. Second, a curriculum learning-based imputation framework is designed to mitigate missing data by progressively leveraging structured variables and unstructured clinical notes to enhance diagnostic robustness under realistic data conditions. Evaluation on the PoseGaze-AHP dataset demonstrates robust diagnostic performance. AHP-CADNet achieves 96.9-99.0 percent accuracy across classification tasks and low prediction errors for continuous variables, with MAE ranging from 0.103 to 0.199 and R2 exceeding 0.93. The imputation framework maintains high accuracy across all clinical variables (93.46-99.78 percent with PubMedBERT), with clinical dependency modeling yielding significant improvements (p < 0.001). These findings confirm the effectiveness of both frameworks for automated diagnosis and recovery from missing data in clinical settings.
Open AccessOcular-Induced Abnormal Head Posture: Diagnosis and Missing Data Imputation
Ocular-induced abnormal head posture (AHP) is a compensatory mechanism that arises from ocular misalignment conditions, such as strabismus, enabling patients to reduce diplopia and preserve binocular vision. Early diagnosis minimizes morbidity and secondary complications such as facial asymmetry; however, current clinical assessments remain largely subjective and are further complicated by incomplete medical records. This study addresses both challenges through two complementary deep learning frameworks. First, AHP-CADNet is a multi-level attention fusion framework for automated diagnosis that integrates ocular landmarks, head pose features, and structured clinical attributes to generate interpretable predictions. Second, a curriculum learning-based imputation framework is designed to mitigate missing data by progressively leveraging structured variables and unstructured clinical notes to enhance diagnostic robustness under realistic data conditions. Evaluation on the PoseGaze-AHP dataset demonstrates robust diagnostic performance. AHP-CADNet achieves 96.9-99.0 percent accuracy across classification tasks and low prediction errors for continuous variables, with MAE ranging from 0.103 to 0.199 and R2 exceeding 0.93. The imputation framework maintains high accuracy across all clinical variables (93.46-99.78 percent with PubMedBERT), with clinical dependency modeling yielding significant improvements (p < 0.001). These findings confirm the effectiveness of both frameworks for automated diagnosis and recovery from missing data in clinical settings.
- Open Access
PoseGaze-AHP: A Knowledge-Based 3D Dataset for AI-Driven Ocular and Postural Diagnosis
Diagnosing ocular-induced abnormal head posture (AHP) requires a comprehensive analysis of both head pose and ocular movements. However, existing datasets focus on these aspects separately, limiting the development of integrated diagnostic approaches and restricting AI-driven advancements in AHP analysis. To address this gap, we introduce PoseGaze-AHP, a novel 3D dataset that synchronously captures head pose and gaze movement information for ocular-induced AHP assessment. Structured clinical data were extracted from medical literature using large language models (LLMs) through an iterative process with the Claude 3.5 Sonnet model, combining stepwise, hierarchical, and complex prompting strategies. The extracted records were systematically imputed and transformed into 3D representations using the Neural Head Avatar (NHA) framework. The dataset includes 7,920 images generated from two head textures, covering a broad spectrum of ocular conditions. The extraction method achieved an overall accuracy of 91.92%, demonstrating its reliability for clinical dataset construction. PoseGaze-AHP is the first publicly available resource tailored for AI-driven ocular-induced AHP diagnosis, supporting the development of accurate and privacy-compliant diagnostic tools.
Open AccessPoseGaze-AHP: A Knowledge-Based 3D Dataset for AI-Driven Ocular and Postural Diagnosis
Diagnosing ocular-induced abnormal head posture (AHP) requires a comprehensive analysis of both head pose and ocular movements. However, existing datasets focus on these aspects separately, limiting the development of integrated diagnostic approaches and restricting AI-driven advancements in AHP analysis. To address this gap, we introduce PoseGaze-AHP, a novel 3D dataset that synchronously captures head pose and gaze movement information for ocular-induced AHP assessment. Structured clinical data were extracted from medical literature using large language models (LLMs) through an iterative process with the Claude 3.5 Sonnet model, combining stepwise, hierarchical, and complex prompting strategies. The extracted records were systematically imputed and transformed into 3D representations using the Neural Head Avatar (NHA) framework. The dataset includes 7,920 images generated from two head textures, covering a broad spectrum of ocular conditions. The extraction method achieved an overall accuracy of 91.92%, demonstrating its reliability for clinical dataset construction. PoseGaze-AHP is the first publicly available resource tailored for AI-driven ocular-induced AHP diagnosis, supporting the development of accurate and privacy-compliant diagnostic tools.
- 22 August 2025
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 29 (5) , 104610
Acquired macular atrophy leads to the correct diagnosis of CLDN19-related disease in a child with nephropathy
- 22 August 2025
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 29 (5) , 104610
Acquired macular atrophy leads to the correct diagnosis of CLDN19-related disease in a child with nephropathy
- 4 March 2025
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 29 (2) , 104159
Acquired torticollis from an upper eyelid ectopic posterior cilium
- 4 March 2025
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 29 (2) , 104159
Acquired torticollis from an upper eyelid ectopic posterior cilium
- 1 September 2024
- Published by Springer Nature
- p. 111-122
Genetics of Childhood Glaucoma
- 17 July 2024
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 45 (6) , 566-570
Usher syndrome in the United Arab Emirates
PurposeUsher syndrome, a common form of syndromic inherited retinal dystrophy in the Arabian Gulf, has not been molecularly defined in the United Arab Emirates. The current study addresses this gap in knowledge.MethodsA retrospective case series of Emirati patients referred to the Ocular Genetics Clinic of Cleveland Clinic Abu Dhabi who (1) were clinically diagnosed with Usher syndrome and underwent genetic testing (whole exome sequencing, 2019 to 2023, inclusive) and (2) were identified to have biallelic pathogenic variants in Usher syndrome genes during the same time period.ResultsTen probands (thirteen patients) were identified-seven probands (nine patients) with clinically diagnosed Usher syndrome and three additional probands (four patients) with biallelic homozygous USH2A variants. Among the seven probands initially diagnosed with Usher syndrome, six had different homozygous variants (three in MYO7A, one in ADGRV1, and one in CLRN1), one had dual diagnoses rather than Usher syndrome (i.e. separate cause for retinal dystrophy and deafness), and one had no identifiable genetic cause. Regarding the three additional probands identified with homozygous USH2A variants, all three had retinitis pigmentosa only rather than Usher syndrome and all three had different variants.DiscussionClinically diagnosed Usher syndrome was genetically heterogenous without evidence for founder effect in this Emirati cohort. MYO7A was the most common associated gene. Dual diagnosis rather than single cause can mimic Usher syndrome. Homozygous USH2A variants were not identified as a cause for Usher syndrome in this cohort but were a recurrent cause for retinitis pigmentosa without hearing impairment and without founder effect.
- 17 July 2024
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 45 (6) , 566-570
Usher syndrome in the United Arab Emirates
PurposeUsher syndrome, a common form of syndromic inherited retinal dystrophy in the Arabian Gulf, has not been molecularly defined in the United Arab Emirates. The current study addresses this gap in knowledge.MethodsA retrospective case series of Emirati patients referred to the Ocular Genetics Clinic of Cleveland Clinic Abu Dhabi who (1) were clinically diagnosed with Usher syndrome and underwent genetic testing (whole exome sequencing, 2019 to 2023, inclusive) and (2) were identified to have biallelic pathogenic variants in Usher syndrome genes during the same time period.ResultsTen probands (thirteen patients) were identified-seven probands (nine patients) with clinically diagnosed Usher syndrome and three additional probands (four patients) with biallelic homozygous USH2A variants. Among the seven probands initially diagnosed with Usher syndrome, six had different homozygous variants (three in MYO7A, one in ADGRV1, and one in CLRN1), one had dual diagnoses rather than Usher syndrome (i.e. separate cause for retinal dystrophy and deafness), and one had no identifiable genetic cause. Regarding the three additional probands identified with homozygous USH2A variants, all three had retinitis pigmentosa only rather than Usher syndrome and all three had different variants.DiscussionClinically diagnosed Usher syndrome was genetically heterogenous without evidence for founder effect in this Emirati cohort. MYO7A was the most common associated gene. Dual diagnosis rather than single cause can mimic Usher syndrome. Homozygous USH2A variants were not identified as a cause for Usher syndrome in this cohort but were a recurrent cause for retinitis pigmentosa without hearing impairment and without founder effect.
- Open Access
- 14 July 2024
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 28 (5) , 103970
Paradoxical keratitis and dermatitis following adalimumab treatment
- 14 July 2024
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 28 (5) , 103970
Open AccessParadoxical keratitis and dermatitis following adalimumab treatment
- 4 June 2024
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 45 (4) , 401-403
Biallelic occult macular dystrophy
Purpose: Occult macular dystrophy (OMD) is a cause of visual loss in young adults with a grossly normal fundus appearance. It is considered an autosomal dominant disorder, related to heterozygous pathogenic variants in the gene RP1L1. The purpose of this study is to report a biallelic form of the disease. Results: A 29-year-old female had undergone neurological workup and ophthalmic examinations for transient visual loss in her left eye over the past two years but there was no definitive diagnosis. The best-corrected visual acuity was 20/30, 20/20. Indirect ophthalmoscopy with a 78D lens revealed subtle central retinal pigment epithelium mottling and optical coherence tomography confirmed subtle central thickening of the ellipsoid zone. Full-field electroretinography was normal, but pattern electroretinography showed decreased p50 responses. OMD was suspected. Retinal gene panel testing was significant only for a homozygous variant in RP1L1 (NM_178857.6: c.3571 G>T; p.Glu1191*). The parents and older brother were unavailable for segregation analysis. By history they did not have visual complaints other than a need for glasses. Conclusions: This report presents the clinical and genetic findings of a biallelic form of OMD associated with a novel pathogenic variant in RP1L1. It would be of interest to carefully assess macular function in heterozygotes with this variant.
- 4 June 2024
- Published by Taylor & Francis in Ophthalmic Genetics
- Vol. 45 (4) , 401-403
Biallelic occult macular dystrophy
Purpose: Occult macular dystrophy (OMD) is a cause of visual loss in young adults with a grossly normal fundus appearance. It is considered an autosomal dominant disorder, related to heterozygous pathogenic variants in the gene RP1L1. The purpose of this study is to report a biallelic form of the disease. Results: A 29-year-old female had undergone neurological workup and ophthalmic examinations for transient visual loss in her left eye over the past two years but there was no definitive diagnosis. The best-corrected visual acuity was 20/30, 20/20. Indirect ophthalmoscopy with a 78D lens revealed subtle central retinal pigment epithelium mottling and optical coherence tomography confirmed subtle central thickening of the ellipsoid zone. Full-field electroretinography was normal, but pattern electroretinography showed decreased p50 responses. OMD was suspected. Retinal gene panel testing was significant only for a homozygous variant in RP1L1 (NM_178857.6: c.3571 G>T; p.Glu1191*). The parents and older brother were unavailable for segregation analysis. By history they did not have visual complaints other than a need for glasses. Conclusions: This report presents the clinical and genetic findings of a biallelic form of OMD associated with a novel pathogenic variant in RP1L1. It would be of interest to carefully assess macular function in heterozygotes with this variant.